Tag: NTLA
Why Intellia Therapeutics is Up $4 Today
Keep an eye on Intellia Therapeutics (NTLA).
Tomorrow, the company will present interim clinical data from its ongoing first-in-human studies of NTLA-2002 and NTLA-2001 for...